Genotype-guided tacrolimus dosing in African-American kidney transplant recipients. - Wikidata - wikimedia - TriplyDB

Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.

Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.

http://www.wikidata.org/entity/Q37009025

about

Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer.Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation.Pharmacogenetic aspects of the use of tacrolimus in renal transplantation: recent developments and ethnic considerations.Overweight Kidney Transplant Recipients Are at Risk of Being Overdosed Following Standard Bodyweight-Based Tacrolimus Starting Dose Transplant genetics and genomics.Impact of CYP3A5 genomic variances on clinical outcomes among African American kidney transplant recipients.Concepts of Genomics in Kidney Transplantation.Early Steroid Withdrawal in Black Transplant Patients: A Selective Process.Genome-wide association study identifies the common variants in CYP3A4 and CYP3A5 responsible for variation in tacrolimus trough concentration in Caucasian kidney transplant recipients.Health Disparities in Kidney Transplantation for African Americans.Genetics of acute rejection after kidney transplantation.Pharmacokinetic considerations related to therapeutic drug monitoring of tacrolimus in kidney transplant patients.Prevalence of CYP3A5 Genomic Variances and Their Impact on Tacrolimus Dosing Requirements among Kidney Transplant Recipients in Eastern North Carolina.

P2860

Q37662607-32CADFCE-6609-4D08-8329-923864A55F7F Q38704635-56373082-3B94-4DC5-A178-F3F1E7D34F6A Q38787174-75F2BE60-EEAF-4238-896B-7EF4DF0AC7F1 Q38865683-DE396F56-14AD-4219-8397-C90F43F7FF0C Q39175303-A3E0D92B-39DB-4062-86D2-BF25CE37B1D4 Q46357849-3B125F84-1B07-48CC-8482-CF0C3B4BD4B5 Q46684824-90057AE2-79F7-4ED2-8D85-4CB9C1449765 Q46777368-E918AFA8-5FFF-4694-82A7-4422AC976B4D Q47436776-5B49503D-CAE9-4A2C-85CC-5C8EC4A4AA72 Q47749734-B0BDF7A1-CF25-4CEC-9D41-ED6E85FE2261 Q47898148-6032ED66-D0BD-47C0-BD6D-52441D5372D3 Q52859440-C43E6B92-EC69-4D66-80D7-C99E5612BE5A Q53228378-3B3D867C-167B-4701-AE03-56A1E05D3123

P2860

Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.

http://www.wikidata.org/entity/Q37009025

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 December 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.

@en

Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.

@nl

type

label

Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.

@en

Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.

@nl

prefLabel

Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.

@en

Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.

@nl

P1433

Q37009025-FD2B0581-294D-4C93-B1E4-814DCC39873E

P1476

Q37009025-22E0C875-0243-4E30-8E6F-2B37E39CFC65

P2093

Q37009025-11A330BF-FE3A-4CAD-9F13-A0E448413563

Q37009025-27114AB7-63FB-4097-9BF6-AB1DDA217CDD

Q37009025-4272FE25-3678-4557-AB37-3E9B05CF4A7D

Q37009025-447C99B6-1EE6-4E83-BE7E-A5DB8DCDE704

Q37009025-954F239B-B0CB-4A63-AE2E-9B491CE700E8

Q37009025-98B7D6D3-939A-44EB-B68C-2D6126ADCD6C

Q37009025-B1B49DF5-E221-43C7-92B7-5AE64AE9EF81

Q37009025-BDC508B7-5FA5-4279-80BD-E122B57C14D7

Q37009025-C06D84A9-FB6F-4A9B-8079-3CEECBB9EB9A

Q37009025-E59F0164-4308-4D66-9E8F-58A495B092F1

P2860

Q37009025-03511FFE-6360-4D99-B1BA-5F16FEB29B8F

Q37009025-04924916-01D8-46AD-A057-E076803E987B

Q37009025-05BB23E5-B8A4-44B1-9254-B87C73C919FF

Q37009025-085DF5C9-3323-446F-9EE5-333C62AD8303

Q37009025-091E32C5-94AC-403D-B325-53CB959D8489

Q37009025-0A291DEB-A096-4968-B52D-B65631D2ABDA

Q37009025-0CB198C8-C8F9-4B1E-B928-37016E040883

Q37009025-0F6209EA-D6B5-4D9E-B846-1256B2EFCA01

Q37009025-10089BF5-2662-4AB7-AEB1-12262BF9C32C

Q37009025-148BC6EE-E7A3-4A09-B35C-EA8345E1541D

P2888

Q37009025-EA59316C-E99C-498E-8579-C816E473C10C

P304

Q37009025-94CEEB08-71FB-4158-A07C-D401463E5EEB

P31

Q37009025-481A25F8-124D-428C-B202-24EB747A73AF

P356

Q37009025-7E24FE45-16F3-450C-9519-2E6294B12018

P433

Q37009025-5F1307E6-1BF0-4606-93BC-0578E71D1CEE

P478

Q37009025-D5B5A9D2-44F2-43A6-ADE4-B6ABB19CAB73

P577

Q37009025-23A4C4B0-8E28-4A4F-8E30-CB048F4FA58F

P6179

Q37009025-45A27ECF-ED51-4CA6-9F20-CDD9B2A1D25D

P698

Q37009025-2D908542-FDE4-4C78-ACCE-4A9C44CA30EF

P932

Q37009025-12BE81FC-F4F5-4140-B00B-DE47CD2994D1

P356

P1433

The Pharmacogenomics Journal

P1476

Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.

@en

P2093

A J Matas

http://www.w3.org/2001/XMLSchema#string

A K Israni

http://www.w3.org/2001/XMLSchema#string

D P Schladt

http://www.w3.org/2001/XMLSchema#string

K Sanghavi

http://www.w3.org/2001/XMLSchema#string

M B Miller

http://www.w3.org/2001/XMLSchema#string

P A Jacobson

http://www.w3.org/2001/XMLSchema#string

R B Mannon

http://www.w3.org/2001/XMLSchema#string

R C Brundage

http://www.w3.org/2001/XMLSchema#string

R P Remmel

http://www.w3.org/2001/XMLSchema#string

W Guan

http://www.w3.org/2001/XMLSchema#string

P2860

An integrated map of genetic variation from 1,092 human genomes

Functionally defective or altered CYP3A4 and CYP3A5 single nucleotide polymorphisms and their detection with genotyping tests

A reporter gene assay to assess the molecular mechanisms of xenobiotic-dependent induction of the human CYP3A4 gene in vitro

OPTN/SRTR 2012 Annual Data Report: kidney.

The pharmacokinetics and metabolic disposition of tacrolimus: a comparison across ethnic groups.

Measurement and compartmental modeling of the effect of CYP3A5 gene variation on systemic and intrarenal tacrolimus disposition.

CYP3A4 and CYP3A5 polymorphisms and blood pressure response to amlodipine among African-American men and women with early hypertensive renal disease

Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery.

CYP3A variation and the evolution of salt-sensitivity variants

PharmGKB summary: cyclosporine and tacrolimus pathways

P2888

P304

61-68

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/TPJ.2015.87

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1037749567

http://www.w3.org/2001/XMLSchema#string

P698

26667830

http://www.w3.org/2001/XMLSchema#string

P932

4909584

http://www.w3.org/2001/XMLSchema#string